CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
about
The IL-17A G-197A and IL-17F 7488T/C polymorphisms are associated with increased risk of cancer in Asians: a meta-analysisCytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.
P2860
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@ast
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@en
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@nl
type
label
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@ast
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@en
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@nl
prefLabel
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@ast
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@en
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@nl
P2093
P2860
P356
P1476
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.
@en
P2093
Andreas O Doesch
Christian A Gleissner
Christian Erbel
Felix Lasitschka
Frederik Jahn
Hamidreza Akhavanpoor
Hugo A Katus
Mohammadreza Akhavanpoor
Stephanie Gorbatsch
Susanne Wangler
P2860
P304
P356
10.2147/DDDT.S72394
P407
P577
2014-11-27T00:00:00Z